BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Levpuscek K, Goricar K, Kovac V, Dolzan V, Franko A. The influence of genetic variability of DNA repair mechanisms on the risk of malignant mesothelioma. Radiol Oncol 2019;53:206-12. [PMID: 30893058 DOI: 10.2478/raon-2019-0016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Fuso Nerini I, Roca E, Mannarino L, Grosso F, Frapolli R, D'Incalci M. Is DNA repair a potential target for effective therapies against malignant mesothelioma? Cancer Treat Rev 2020;90:102101. [PMID: 32892058 DOI: 10.1016/j.ctrv.2020.102101] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Dubois F, Bazille C, Levallet J, Maille E, Brosseau S, Madelaine J, Bergot E, Zalcman G, Levallet G. Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP. Target Oncol 2022;17:407-31. [PMID: 35906513 DOI: 10.1007/s11523-022-00900-2] [Reference Citation Analysis]
3 Piber P, Vavpetic N, Goricar K, Dolzan V, Kovac V, Franko A. The influence of genetic variability in IL1B and MIR146A on the risk of pleural plaques and malignant mesothelioma. Radiol Oncol 2020;54:429-36. [PMID: 33085641 DOI: 10.2478/raon-2020-0057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Malakoti F, Targhazeh N, Abadifard E, Zarezadeh R, Samemaleki S, Asemi Z, Younesi S, Mohammadnejad R, Hadi Hossini S, Karimian A, Alemi F, Yousefi B. DNA repair and damage pathways in mesothelioma development and therapy. Cancer Cell Int 2022;22:176. [PMID: 35501851 DOI: 10.1186/s12935-022-02597-9] [Reference Citation Analysis]